Osaic Holdings
TNDM icon

Osaic Holdings’s Tandem Diabetes Care TNDM Stock Holding History

Osaic Holdings’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$46.9K Buy
3,111
+523
+20% +$9.13K ﹤0.01% 5538
2026
Q1 		$49.6K Sell
2,588
-28
-1% -$608 ﹤0.01% 5227
2025
Q4 		$57.5K Sell
2,616
-5,871
-69% -$106K ﹤0.01% 5140
2025
Q3 		$106K Sell
8,487
-792
-9% -$10.7K ﹤0.01% 4731
2025
Q2 		$173K Buy
9,279
+145
+2% +$2.87K ﹤0.01% 4058
2025
Q1 		$175K Buy
9,134
+3,405
+59% +$99.6K ﹤0.01% 3740
2024
Q4 		$206K Sell
5,729
-2,784
-33% -$94.2K ﹤0.01% 3566
2024
Q3 		$361K Buy
8,513
+112
+1% +$4.75K ﹤0.01% 3166
2024
Q2 		$338K Sell
8,401
-173
-2% -$7.22K ﹤0.01% 3096
2024
Q1 		$304K Sell
8,574
-10,481
-55% -$281K ﹤0.01% 3331
2023
Q4 		$564K Sell
19,055
-2,485
-12% -$51.6K ﹤0.01% 3050
2023
Q3 		$447K Buy
21,540
+4,832
+29% +$133K ﹤0.01% 3342
2023
Q2 		$410K Buy
16,708
+1,951
+13% +$62.8K ﹤0.01% 3312
2023
Q1 		$599K Sell
14,757
-2,573
-15% -$107K ﹤0.01% 2930
2022
Q4 		$779K Sell
17,330
-739
-4% -$33.5K ﹤0.01% 2617
2022
Q3 		$864K Buy
18,069
+1,791
+11% +$98.2K ﹤0.01% 2368
2022
Q2 		$970K Buy
16,278
+2,334
+17% +$192K ﹤0.01% 2298
2022
Q1 		$1.47M Sell
13,944
-15
-0.1% -$1.75K ﹤0.01% 2204
2021
Q4 		$2.1M Buy
13,959
+8,660
+163% +$1.17M ﹤0.01% 1743
2021
Q3 		$639K Buy
5,299
+312
+6% +$34.4K ﹤0.01% 2779
2021
Q2 		$486K Sell
4,987
-340
-6% -$30.3K ﹤0.01% 3058
2021
Q1 		$467K Sell
5,327
-1,208
-18% -$112K ﹤0.01% 2927
2020
Q4 		$626K Sell
6,535
-1,089
-14% -$112K ﹤0.01% 2439
2020
Q3 		$818K Buy
7,624
+651
+9% +$68.4K ﹤0.01% 2002
2020
Q2 		$689K Sell
6,973
-26,671
-79% -$2.13M ﹤0.01% 2066
2020
Q1 		$521K Buy
+33,644
New +$2.36M ﹤0.01% 2057

Other funds holding TNDM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SC
Sessa Capital New York $5.98B AUM 99.85% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $12.8B AUM 48.82% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $627M AUM 43.41% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return

Osaic Holdings's TNDM Position: Q2 2026 in Review

Osaic Holdings increased its Tandem Diabetes Care (TNDM) stake by 20% in Q2 2026, buying an estimated $9.13K and bringing the position to 3,111 shares worth $46.9K. The position accounts for ﹤0.01% of the portfolio, ranked #5538.

Osaic Holdings first reported a position in TNDM in Q1 2020 and has held it in 26 quarters since. The position peaked at $2.1M in Q4 2021. 274 funds tracked by Wall St. Rank hold TNDM as of Q2 2026.

  • Osaic Holdings held 3,111 shares of Tandem Diabetes Care worth $46.9K as of Q2 2026.
  • Osaic Holdings bought 523 Tandem Diabetes Care shares in Q2 2026, an estimated $9.13K.
  • Tandem Diabetes Care made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #5538 holding.
  • Osaic Holdings first reported a position in Tandem Diabetes Care in Q1 2020 and has held it in 26 quarters since.
  • Osaic Holdings's Tandem Diabetes Care position peaked at $2.1M in Q4 2021.
  • 274 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.